38 related articles for article (PubMed ID: 2940298)
1. The antitumor effects of levamisole in mice are mediated by NC-1.1+ cells.
Clarke GR; Burton RC; Smart YC
Cancer Immunol Immunother; 1997 Oct; 45(2):115-8. PubMed ID: 9390203
[TBL] [Abstract][Full Text] [Related]
2. Mast cells as sources of cytokines, chemokines, and growth factors.
Mukai K; Tsai M; Saito H; Galli SJ
Immunol Rev; 2018 Mar; 282(1):121-150. PubMed ID: 29431212
[TBL] [Abstract][Full Text] [Related]
3. Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.
Bernard MP; Bancos S; Sime PJ; Phipps RP
Curr Pharm Des; 2008; 14(21):2051-60. PubMed ID: 18691115
[TBL] [Abstract][Full Text] [Related]
4. Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor.
Young JD; Liu CC; Butler G; Cohn ZA; Galli SJ
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9175-9. PubMed ID: 3321069
[TBL] [Abstract][Full Text] [Related]
5. Presence of tumour necrosis factor or a related factor in human basophil/mast cells.
Steffen M; Abboud M; Potter GK; Yung YP; Moore MA
Immunology; 1989 Mar; 66(3):445-50. PubMed ID: 2703257
[TBL] [Abstract][Full Text] [Related]
6. IgE and immune defense mechanism.
Dessaint JP; Capron A
Clin Rev Allergy; 1989; 7(1):105-22. PubMed ID: 2524248
[No Abstract] [Full Text] [Related]
7. Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion.
Klein LM; Lavker RM; Matis WL; Murphy GF
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8972-6. PubMed ID: 2479033
[TBL] [Abstract][Full Text] [Related]
8. Fc epsilon receptor II-positive macrophages and platelets: potent effector cells in allergy and defence against helminth parasites.
Dessaint JP; Capron A
Springer Semin Immunopathol; 1990; 12(4):349-63. PubMed ID: 2151404
[No Abstract] [Full Text] [Related]
9. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha.
Wershil BK; Wang ZS; Gordon JR; Galli SJ
J Clin Invest; 1991 Feb; 87(2):446-53. PubMed ID: 1991831
[TBL] [Abstract][Full Text] [Related]
10. Regulation of tumor necrosis factor production by monocyte-macrophages and lymphocytes.
Trinchieri G
Immunol Res; 1991; 10(2):89-103. PubMed ID: 1919171
[No Abstract] [Full Text] [Related]
11. Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells.
Murphy GF; Whitaker D; Sprent J; Korngold R
Am J Pathol; 1991 Apr; 138(4):983-90. PubMed ID: 1901455
[TBL] [Abstract][Full Text] [Related]
12. Sequential mast cell infiltration and degranulation during experimental carcinogenesis.
Flynn EA; Schwartz JL; Shklar G
J Cancer Res Clin Oncol; 1991; 117(2):115-22. PubMed ID: 1901064
[TBL] [Abstract][Full Text] [Related]
13. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1.
Walsh LJ; Trinchieri G; Waldorf HA; Whitaker D; Murphy GF
Proc Natl Acad Sci U S A; 1991 May; 88(10):4220-4. PubMed ID: 1709737
[TBL] [Abstract][Full Text] [Related]
14. Natural cytotoxic (NC) cell activity in basophilic cells: release of NC-specific cytotoxic factor by IgE receptor triggering.
Okuno T; Takagaki Y; Pluznik DH; Djeu JY
J Immunol; 1986 Jun; 136(12):4652-8. PubMed ID: 2940298
[TBL] [Abstract][Full Text] [Related]
15. Natural cytotoxic cell-specific cytotoxic factor produced by IL-3-dependent basophilic/mast cells. Relationship to TNF.
Richards AL; Okuno T; Takagaki Y; Djeu JY
J Immunol; 1988 Nov; 141(9):3061-6. PubMed ID: 3262677
[TBL] [Abstract][Full Text] [Related]
16. Gene expression and production of tumour necrosis factor by a rat basophilic leukaemia cell line (RBL-2H3) with IgE receptor triggering.
Ohno I; Tanno Y; Yamauchi K; Takishima T
Immunology; 1990 May; 70(1):88-93. PubMed ID: 2141321
[TBL] [Abstract][Full Text] [Related]
17. Natural cytotoxic activity in a cloned natural killer cell line is mediated by tumor necrosis factor.
Richards AL; Dennert G; Pluznik DH; Takagaki Y; Djeu JY
Nat Immun Cell Growth Regul; 1989; 8(2):76-88. PubMed ID: 2761550
[TBL] [Abstract][Full Text] [Related]
18. Review: Diagnostic and therapeutic applications of rat basophilic leukemia cells.
Rashid A; Sadroddiny E; Ye HT; Vratimos A; Sabban S; Carey E; Helm B
Mol Immunol; 2012 Oct; 52(3-4):224-8. PubMed ID: 22750069
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
